Clinical Trial Update: Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma [NA]

View source ↗

Summary

Results from a completed clinical trial examining immune reconstitution after autologous hematopoietic stem cell transplantation in high-risk lymphoma; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma
• Plasma Cell Neoplasm
• Small Intestine Cancer

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | NA | Status: COMPLETED | Results posted: 2018-03-12